Andrey S. Dobroff

2.0k citations

35 papers · 1.2k indexed · h-index 21

Molecular Biology top 10%
Immunology top 10%
Oncology top 10%
Cancer Research top 10%
Microbiology top 5%

Co-authors: Menashe Bar‐Eli Maya Zigler Gabriel J. Villares Vladislava O. Melnikova Luiz R. Travassos Russell R. Braeuer Renata Pasqualini Elaine G. Rodrigues
Topics: Monoclonal and Polyclonal Antibodies Research (9 papers)Cell Adhesion Molecules Research (8 papers)Antimicrobial Peptides and Activities (5 papers)
Cited by: Microbiology Immunology and Allergy Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Brazil Italy

In The Last Decade

Andrey S. Dobroff

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Andrey S. Dobroff

Since Specialization

Citations

This map shows the geographic impact of Andrey S. Dobroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey S. Dobroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey S. Dobroff more than expected).

Fields of papers citing papers by Andrey S. Dobroff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey S. Dobroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey S. Dobroff. The network helps show where Andrey S. Dobroff may publish in the future.

Co-authorship network of co-authors of Andrey S. Dobroff

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey S. Dobroff. A scholar is included among the top collaborators of Andrey S. Dobroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey S. Dobroff. Andrey S. Dobroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peptide L13S Derived from the BRN2 POU Domain Reduces MetastasisIn Vivoand Inhibits Cell Migration and InvasionIn Vitro 2023 ·Anticancer Research ·(unknown),Renato A. Mortara,(unknown),(unknown),Thaysa Paschoalin,(unknown),(unknown),(unknown),Dayane Batista Tada,Andrey S. Dobroff,Denise C. Arruda	0
2	Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts 2023 ·eLife ·Richard C. Lauer,Marc Barry,Tracey L. Smith,Andrew Maltez Thomas,(unknown),Ruofei Du,Ji‐Hyun Lee,Arpit Rao,Andrey S. Dobroff,Marco A. Arap,Diana Noronha Nunes,Israel Tojal da Silva,Emmanuel Dias‐Neto,Isan Chen,Dennis J. McCance,Webster K. Cavenee,Renata Pasqualini,Wadih Arap	2
3	Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature 2022 ·Biomedicines ·(unknown),(unknown),Andrey S. Dobroff,Edmund Chada Baracat,Qiwei Yang,Ayman Al‐Hendy,Kátia Cândido Carvalho	8
4	Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial 2022 ·eLife ·Montaser Shaheen,Julie Y. Tse,Ethan Sokol,Margaret Masterson,Pranshu Bansal,Ian Rabinowitz,Christy A. Tarleton,Andrey S. Dobroff,Tracey L. Smith,Thèrése Bocklage,(unknown),Ryan N. Gutenkunst,Joyce Bischoff,Scott A. Ness,Gregory Riedlinger,Roman Groisberg,Renata Pasqualini,Shridar Ganesan,Wadih Arap	9
5	Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis 2021 ·International Journal of Molecular Sciences ·(unknown),(unknown),(unknown),Glauco Baiocchi,Fernando Augusto Soares,Rafael Malagoli Rocha,Edmund Chada Baracat,Andrey S. Dobroff,Kátia Cândido Carvalho	2
6	Intracellular targeting of annexin A2 inhibits tumor cell adhesion, migration, and in vivo grafting 2017 ·Scientific Reports ·Daniela I. Staquicini,Roberto Rangel,Liliana Guzman‐Rojas,Fernanda I. Staquicini,Andrey S. Dobroff,Christy A. Tarleton,Michelle A. Ozbun,Mikhail G. Kolonin,Juri G. Gelovani,Serena Marchiò,Richard L. Sidman,Katherine A. Hajjar,Wadih Arap,Renata Pasqualini	39
7	Ligand-targeted theranostic nanomedicines against cancer 2016 ·Journal of Controlled Release ·Virginia J. Yao,Sara D’Angelo,Kimberly S. Butler,Christophe Théron,Tracey L. Smith,Serena Marchiò,Juri G. Gelovani,Richard L. Sidman,Andrey S. Dobroff,C. Jeffrey Brinker,Andrew Bradbury,Wadih Arap,Renata Pasqualini	152
8	Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis 2015 ·Proceedings of the National Academy of Sciences ·Dawn R. Christianson,Andrey S. Dobroff,Bettina Proneth,Amado J. Zurita,Ahmad Salameh,Eleonora Dondossola,Junichiro Makino,Cristian Bologa,Tracey L. Smith,Virginia J. Yao,Tiffany L. Calderone,David O’Connell,Tudor I. Oprea,Kazunori Kataoka,Dolores J. Cahill,Jeffrey E. Gershenwald,Richard L. Sidman,Wadih Arap,Renata Pasqualini	12
9	Targeting mammalian organelles with internalizing phage (iPhage) libraries 2013 ·Nature Protocols ·Roberto Rangel,Andrey S. Dobroff,Liliana Guzman‐Rojas,(unknown),Juri G. Gelovani,Richard L. Sidman,Renata Pasqualini,Wadih Arap	21
10	Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin 2012 ·Cancer Research ·Russell R. Braeuer,Maya Zigler,Takafumi Kamiya,Andrey S. Dobroff,Li Huang,Woonyoung Choi,David J. McConkey,Einav Shoshan,Aaron K. Mobley,Renduo Song,Avraham Raz,Menashe Bar‐Eli	81
11	β-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma 2012 ·Journal of Biological Chemistry ·Denise C. Arruda,(unknown),(unknown),Felipe V. Pereira,Carlos R. Figueiredo,Alisson L. Matsuo,Renato A. Mortara,María A. Juliano,Elaine G. Rodrigues,Andrey S. Dobroff,Luciano Polonelli,Luiz R. Travassos	39
12	Expression of Id-1 Is Regulated by MCAM/MUC18: A Missing Link in Melanoma Progression 2011 ·Cancer Research ·Maya Zigler,Gabriel J. Villares,Andrey S. Dobroff,Hua Wang,Li Huang,Russell R. Braeuer,Takafumi Kamiya,Vladislava O. Melnikova,Renduo Song,Ran Friedman,Rhoda M. Alani,Menashe Bar‐Eli	36
13	A phase II study of gefitinib in patients with metastatic melanoma 2011 ·Melanoma Research ·Sapna P. Patel,Kevin B. Kim,Nicholas E. Papadopoulos,Wen-Jen Hwu,Patrick Hwu,Víctor G. Prieto,Menashe Bar‐Eli,Maya Zigler,Andrey S. Dobroff,Yulia Bronstein,Roland L. Bassett,(unknown),Agop Y. Bedikian	30
14	Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment 2010 ·Seminars in Cancer Biology ·Russell R. Braeuer,Maya Zigler,Gabriel J. Villares,Andrey S. Dobroff,Menashe Bar‐Eli	68
15	Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells 2010 ·Translational Oncology ·Andrey S. Dobroff,Elaine G. Rodrigues,María A. Juliano,(unknown),Ernesto Nakayasu,Igor C. Almeida,Renato A. Mortara,Jacqueline F. Jacysyn,Gustavo P. Amarante‐Mendes,Walter Magliani,Stefania Conti,Luciano Polonelli,Luiz R. Travassos	25
16	CREB Inhibits AP-2α Expression to Regulate the Malignant Phenotype of Melanoma 2010 ·PLoS ONE ·Vladislava O. Melnikova,Andrey S. Dobroff,Maya Zigler,Gabriel J. Villares,Russell R. Braeuer,Hua Wang,Li Huang,Menashe Bar‐Eli	51
17	Overexpression of Protease-Activated Receptor-1 Contributes to Melanoma Metastasis via Regulation of Connexin 43 2009 ·Cancer Research ·Gabriel J. Villares,Andrey S. Dobroff,Hua Wang,Maya Zigler,Vladislava O. Melnikova,Huang Li,Menashe Bar‐Eli	46
18	Differential effects of α-helical and β-hairpin antimicrobial peptides against Acanthamoeba castellanii 2009 ·Parasitology ·(unknown),Rafael M. Martins,Antônio Miranda,Andrey S. Dobroff,Sirlei Daffre,Annette Silva Foronda,Denise de Freitas,Sérgio Schenkman	16
19	Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities 2008 ·PLoS ONE ·Luciano Polonelli,José Pontón,Natalia Elguezábal,Marı́a D. Moragues,Claudio Casoli,Elisabetta Pilotti,Paola Ronzi,Andrey S. Dobroff,Elaine G. Rodrigues,María A. Juliano,(unknown),Walter Magliani,Stefania Conti,Luiz R. Travassos	70
20	Protective, Anti-Tumor Monoclonal Antibody Recognizes a Conformational Epitope Similar to Melibiose at the Surface of Invasive Murine Melanoma Cells 2002 ·PubMed ·Andrey S. Dobroff,Elaine G. Rodrigues,Jane Zveiter de Moraes,Luiz R. Travassos	18

About Andrey S. Dobroff

Andrey S. Dobroff is a scholar working on Immunology and Allergy, Microbiology and Cancer Research, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cell Adhesion Molecules Research (8 papers) and Antimicrobial Peptides and Activities (5 papers). The work is most often cited by research in Microbiology (141 citations), Immunology and Allergy (84 citations) and Immunology (270 citations). Andrey S. Dobroff has collaborated with scholars based in United States, Brazil and Italy. Frequent co-authors include Menashe Bar‐Eli, Maya Zigler, Gabriel J. Villares, Vladislava O. Melnikova, Luiz R. Travassos, Russell R. Braeuer, Renata Pasqualini, Elaine G. Rodrigues, Wadih Arap and Richard L. Sidman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact